Loading chart…
CLOSED
Granules India Limited manufactures and sells active pharmaceutical ingredients (APIs), pharmaceutical formulation intermediates (PFIs), finished dosages (FDs), and peptides CDMO in India and internationally. It offers paracetamol, metformin, guaifenesin, ibuprofen, and methocarbamol, as well as prescription and over-the-counter products. The company also develops and manufactures tablets, capsules, press fits, oral solutions, suspensions, and powder for oral solutions.
Granules India Limited (GRANULES) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The GRANULES share price is ₹790.10 (-1.19% today), with a market capitalisation of ₹216B and a price-to-earnings (P/E) ratio of 27.7. MarketRipple tracks the GRANULES investment thesis, the ripple-chain impact of market events on Granules India Limited, and the Healthcare sector outlook.
Open
₹800.80
High
₹808.00
Low
₹786.10
Prev. Close
₹799.65
52W High
₹923.65
52W Low
₹529.85
Day range
₹786.10–₹808.00
52-week range
₹529.85–₹923.65
Volume
1.0M
P/E
27.7
ROE
13.5%
D/E
0.30
Margin
12.1%
Granules India Limited (NSE: GRANULES) is currently trading at ₹790.10 (-1.19%).
Granules India Limited's market capitalization is ₹216B.
Granules India Limited's price-to-earnings (P/E) ratio is 27.7.
Granules India Limited operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).
Analyst consensus on Granules India Limited currently reads strongly positive, based on 8 analysts covering the stock. This is third-party analyst data, not a MarketRipple recommendation.